Literature DB >> 8725737

Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarin anticoagulation.

P Prandoni, P Simioni, A Girolami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8725737

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  9 in total

Review 1.  Treatment of the antiphospholipid antibody syndrome: progress in the last five years?

Authors:  M Petri
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

Review 2.  The epidemiology of the antiphospholipid syndrome: who is at risk?

Authors:  G Finazzi
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

3.  Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban.

Authors:  Ida Martinelli; Maria Abbattista; Paolo Bucciarelli; Armando Tripodi; Andrea Artoni; Francesca Gianniello; Cristina Novembrino; Flora Peyvandi
Journal:  Haematologica       Date:  2018-03-08       Impact factor: 9.941

4.  Hypercoagulable states in patients with retinal venous occlusion.

Authors:  A M Abu El-Asrar; A G Abdel Gader; S Al-Amro; A K Al-Momen
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

Review 5.  Clinical utilization of the international normalized ratio (INR).

Authors:  R S Riley; D Rowe; L M Fisher
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

6.  Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.

Authors:  N R Bijsterveld; S Middeldorp; F Berends; H R Büller
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

Review 7.  Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.

Authors:  Cecilia Beatrice Chighizola; Tania Ubiali; Pier Luigi Meroni
Journal:  J Immunol Res       Date:  2015-05-05       Impact factor: 4.818

Review 8.  Management of the antiphospholipid syndrome.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Auto Immun Highlights       Date:  2010-07-10

9.  Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.

Authors:  Daniel E Pleguezuelo; Raquel Díaz-Simón; Oscar Cabrera-Marante; Antonio Lalueza; Estela Paz-Artal; Carlos Lumbreras; Antonio Serrano Hernández
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.